Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Virinchi Ltd

VIRINCHI
NSE
18.17
1.00%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Virinchi Ltd

VIRINCHI
NSE
18.17
1.00%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
199Cr
Close
Close Price
18.17
Industry
Industry
IT - Software
PE
Price To Earnings
PS
Price To Sales
0.69
Revenue
Revenue
287Cr
Rev Gr TTM
Revenue Growth TTM
-6.36%
PAT Gr TTM
PAT Growth TTM
-331.56%
Peer Comparison
How does VIRINCHI stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
VIRINCHI
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
788073737576748269806277
Growth YoY
Revenue Growth YoY%
-7.06.0-8.2-8.4-4.2-6.02.413.6-7.75.6-16.8-6.7
Expenses
ExpensesCr
435050444754505652545151
Operating Profit
Operating ProfitCr
353022292822242717261126
OPM
OPM%
45.037.230.539.937.628.832.432.424.432.717.133.4
Other Income
Other IncomeCr
101041006000
Interest Expense
Interest ExpenseCr
11111011111010910988
Depreciation
DepreciationCr
111513141213131614141414
PBT
PBTCr
154058022-13-124
Tax
TaxCr
3-1-106-11-23323
PAT
PATCr
124162104-40-142
Growth YoY
PAT Growth YoY%
395.5343.6141.5-6.3-83.2-76.2-88.4-33.1-317.6-64.8-8,141.2-56.9
NPM
NPM%
15.65.52.07.72.71.40.24.5-6.40.5-22.12.1
EPS
EPS
1.50.50.20.60.20.10.00.4-0.40.0-1.30.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
139218287341407381354364312300301287
Growth
Revenue Growth%
22.857.331.319.119.2-6.3-7.22.8-14.3-3.80.4-4.6
Expenses
ExpensesCr
117187223246287271258264206191212208
Operating Profit
Operating ProfitCr
22316496120111961001061098979
OPM
OPM%
15.914.322.328.129.529.027.027.434.036.429.627.5
Other Income
Other IncomeCr
2221421134577
Interest Expense
Interest ExpenseCr
2312182222322633433935
Depreciation
DepreciationCr
111225333645484856545556
PBT
PBTCr
111830466646222821172-6
Tax
TaxCr
326137-1191484210
PAT
PATCr
8162433594631413130-16
Growth
PAT Growth%
113.895.545.640.078.4-21.1-94.3428.2-9.96.0-96.4-3,434.0
NPM
NPM%
6.07.48.29.714.512.20.83.94.14.50.2-5.6
EPS
EPS
2.34.54.45.89.47.10.31.81.61.50.1-1.6

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
18182728313337798494103103
Reserves
ReservesCr
89106180221281341338292314353373359
Current Liabilities
Current LiabilitiesCr
24488311610488100100114137123113
Non Current Liabilities
Non Current LiabilitiesCr
1993128122114104212233266260250259
Total Liabilities
Total LiabilitiesCr
150264418494535567687703787851847831
Current Assets
Current AssetsCr
468689153148157173195206209183192
Non Current Assets
Non Current AssetsCr
104178329341387410514509581642664640
Total Assets
Total AssetsCr
150264418494535567687703787851847831

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
122379358185508212711684
Investing Cash Flow
Investing Cash FlowCr
-3-94-126-51-83-68-154-34-137-114-78
Financing Cash Flow
Financing Cash FlowCr
27331141-17115-314-13-19
Net Cash Flow
Net Cash FlowCr
112-16-1-101018-6-11-12
Free Cash Flow
Free Cash FlowCr
9-70-46-15-317-1250-935
CFO To PAT
CFO To PAT%
139.2141.2334.2106.6137.6183.51,865.2581.91,002.0863.217,347.4
CFO To EBITDA
CFO To EBITDA%
52.173.5123.536.767.577.152.282.4120.0106.794.1

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
345931029125786129463314288214
Price To Earnings
Price To Earnings
4.13.613.18.84.31.947.032.424.321.0297.6
Price To Sales
Price To Sales
0.30.31.10.80.60.20.41.31.01.00.7
Price To Book
Price To Book
0.30.51.51.20.80.20.31.30.80.60.5
EV To EBITDA
EV To EBITDA
1.84.67.24.63.42.13.97.05.75.55.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
99.999.997.996.594.293.893.592.493.795.395.3
OPM
OPM%
15.914.322.328.129.529.027.027.434.036.429.6
NPM
NPM%
6.07.48.29.714.512.20.83.94.14.50.2
ROCE
ROCE%
9.69.111.215.618.612.88.48.47.57.85.4
ROE
ROE%
7.713.111.413.318.912.40.73.83.23.00.1
ROA
ROA%
5.56.15.76.711.08.20.42.01.61.60.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **1. Company Overview** Founded in 1990 and headquartered in Hyderabad, India, **Virinchi Limited** is a diversified technology-led group operating at the intersection of **fintech, healthcare, IT services, and data science**. It leverages deep expertise in artificial intelligence, machine learning (ML), and digital platforms to create scalable, asset-light businesses across high-growth sectors. The company is led by a team with strong academic credentials (IIT/IIM background) and operates through a portfolio of subsidiaries, balancing innovation with financial discipline. Over the years, it has evolved from an IT services firm into a multi-vertical organization with globally recognized products and services. --- ### **2. Core Business Verticals** Virinchi operates four primary business segments, unified by shared technological foundations in AI, data analytics, and process automation: #### **A. US Fintech (QFund – SaaS Platform)** - **Product**: *QFund™*, a cloud-based SaaS platform for the US alternative finance industry, primarily serving subprime lending institutions. - **Launch**: 2002; established as a market leader in micro-lending technology. - **Market Position**: Processes ~450,000 loans/month, managing $3B+ in annual disbursements, across 18 licensed lenders in 45 U.S. states. - **Clients**: Serves 4 of the top 5 alternative lenders in the U.S., with ~70% of IT revenue coming from clients with 8+ years of partnership. - **FY24–25 Revenue**: ₹133.37 crore (69.9% of total IT revenue). - **Key Highlights**: - Transitioning to **multi-tenant SaaS architecture** powered by **agentic AI**, drastically reducing onboarding time and operational costs. - **Pay-per-use model** aligns revenue with client adoption; strong customer retention and organic growth via referrals. - Industry consolidation drives expansion—recently scaled operations for a major client post-acquisition. - Exploring international replication (Canada) and plans to enter Indian and SME lending markets. #### **B. Healthcare Services (Virinchi Hospitals)** - **Flagship Facility**: 600-bed tertiary care hospital in Banjara Hills, Hyderabad (30-year lease), equipped with cutting-edge infrastructure: - 11 modular OTs, 3T fMRI, 128-slice dual-energy CT, 130 ICU beds. - Fully NABH-accredited with integrated HIS/EMR via acquired subsidiary *Asclepius Consulting & Technologies*. - **Other Facilities**: Two smaller hospitals (Barkatpura & Hayathnagar), totaling 600 licensed beds. - **Expansion Projects**: - 100-bed oncology block in Banjara Hills (scheduled completion: March 2027). - 300-bed multi-specialty hospital under construction in Visakhapatnam (expected FY2025–26). - Near-term bed capacity outlook: **1,100 beds**; long-term goal: **5,000 beds**. - **FY24–25 Performance**: - Revenue: ₹104 crore (34.6% of total operating revenue). - EBITDA Contribution: 27.7%, despite -12.5% YoY revenue growth due to strategic reinvestment. - **Strategic Vision**: - Evolve into **proactive, wellness-focused ecosystems** powered by predictive analytics. - Target **1 billion patients** in a decade via a unified digital health platform. - Expand into underserved eastern India and leverage telemedicine (omnichannel model) for scalable outreach. - Innovations: Stem cell therapy for osteoarthritis (first in Telangana), transplants, and “Right to Science” partnerships with U.S., U.K., and Israeli institutions. #### **C. Indian Fintech (vCard – Payment & Credit Services)** - **Launch**: 2019; India’s **first mobile-based, UPI-linked "downloadable" credit card**. - **Model**: Partners with banks and NBFCs (e.g., RBL Bank, Pinnacle Capital) to deliver credit to **underserved, low-income populations**. - **Product Offerings**: - **Credit Cards (Bank Partnership Model)**: Co-branded with banks; digital sub-limit of ₹20,000 via UPI app. - **Digital Credit Line (NBFC Partnership)**: Instant approval (₹1,000–5,000); cash transfer + EMI conversion. - **Technology**: - AI-driven underwriting using PAN, Aadhaar, UPI spend, and GST data; assesses users **without CIBIL history**. - One of the **lowest credit origination costs globally (~₹30/card)** due to digital, AI-powered workflows. - PCI DSS compliant; uses Cashfree (payments), TransUnion (credit checks), and IDfy (eKYC). - **User Engagement**: - 1.2M+ app installs; 25,000+ cumulative customers; >₹80 crore UPI transactions processed. - Active credit book: ₹20.56 crore; disbursements over $50 million. - **FY24–25 Performance**: - Revenue: ₹6.31 crore; EBIT loss ₹3.33 crore (investing phase). - **Growth Strategy**: - Scale through **new banking partnerships** after discontinuing a previous alliance for operational reasons. - Aggressively target **debit card users and blue-collar workers** as credit adopters. - Projected to become a **$1B revenue business within 5 years**, serving 600M+ underbanked Indians. #### **D. IT & IDC Services (KSoft Systems Inc.)** - **Subsidiary**: KSoft Systems Inc. (U.S.-based), operating since 2006. - **Services**: Enterprise IT solutions in SMAC (Social, Mobility, Analytics, Cloud), ERP, data analytics, and custom application development. - **Clients**: 90%+ in tech, telecom, and banking sectors; known for speed, scalability, and precision. - **Infrastructure**: - SOC-2 certified **data centers in California and Atlanta**. - Developing third-party data center services; evaluating entry when commissioning costs per MW decline. - **FY24–25 Performance**: - Revenue: ₹57.30 crore; FY23–24 growth: 27.6%. - EBIT: ₹18.59 crore (positive). - **Client Model**: Onsite, offshore, hybrid delivery; 75-person U.S. team, 150+ offshore. - **AI Integration**: Used across healthcare, fintech, and IT projects to improve efficiency, compliance, and customer experience. --- ### **3. Strategic Enablers** - **Artificial Intelligence & Data Science**: - Embedded across all verticals—AI drives credit scoring (vCard), reduces disbursement time (QFund), and enhances hospital operations (automated discharge summaries, scheduling). - Subsidiary *Virinchi Combinatorics & Systems Biology* has mapped **95% of unexplored biological system dimensions**, signaling deep R&D capability. - **Asset-Light Expansion**: - Leverages long-term leases (e.g., 30-year hospital lease in super mall) to minimize capex and maintain a **low-debt, high-liquidity balance sheet**. - Funds new ventures (e.g., data centers, fintech) using **annuity revenues from mature businesses** (QFund, IT services). - **Synergistic Business Model**: - Shared tech stack enables cross-vertical learning (e.g., U.S. credit models inform India’s vCard). - Proprietary machine learning engines trained on over **28 million U.S. financial profiles**. --- ### **4. Key Financial & Operational Metrics (FY24–25)** | Segment | Revenue (₹ Crore) | % of Total | EBITDA Contribution | Notes | |----------------------------|-------------------|------------|----------------------|-------| | QFund (US SaaS) | 133.37 | ~70% of IT rev | N/A | SaaS margin, pay-per-use model | | Healthcare Services | 104.00 | 34.6% of total | 27.7% | Growth phase, -12.5% YoY revenue | | IT & IDC Services (KSoft) | 57.30 | 30.1% of IT | Positive (₹18.59 Cr) | 27.6% YoY growth | | vCard (India Fintech) | 6.31 | Segment loss | ₹-3.33 Cr | Pre-scaling investment phase | > **Note**: The company’s diversified model has led to investor confusion; management acknowledges that **each vertical could command standalone valuation** if separated. --- ### **5. Recent Developments (2024–25)** - **Healthcare**: - Commissioned stem cell therapy programs; performing transplants across states. - Preparing to launch oncology block in Hyderabad (2027) and new facility in Vizag. - Expanding telemedicine footprint to Tier 2/3 cities. - **Fintech**: - Onboarding new banking partners to scale vCard; targeting 50,000+ customers in FY25–26. - vCard platform enhances user experience with AI, EMI conversion, interest-free credit, and zero-touch support. - **Technology**: - Modernized UX for QFund; launched machine learning underwriting engine. - Exploring multi-tenancy SaaS, AI integration, and automated client scaling. - **Investor Confidence**: - A long-term U.S. QFund client invested **$2M via convertible debentures** 30 months ago. - **Global Expansion**: - Incorporated **Virinchi Technologies Limited in Canada**, not yet operational.